DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
An increasing number of evidences have shown that the carcinogenic effect of DRAXIN plays an important role in the malignant process of tumors, but the mechanism of its involvement in glioma has not yet been revealed. The main aim of this study is to explore the relationship between DRAXIN and the p...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596576/ https://www.ncbi.nlm.nih.gov/pubmed/36040678 http://dx.doi.org/10.1007/s12031-022-02054-2 |